Champions Oncology
CSBR
CSBR
30 hedge funds and large institutions have $23.6M invested in Champions Oncology in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.05% less ownership
Funds ownership: 44.28% → 43.22% (-1.1%)
11% less capital invested
Capital invested by funds: $26.5M → $23.6M (-$2.97M)
50% less call options, than puts
Call options by funds: $33K | Put options by funds: $66K
Holders
30
Holding in Top 10
1
Calls
$33K
Puts
$66K
Top Buyers
| 1 | +$202K | |
| 2 | +$104K | |
| 3 | +$89.7K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$6.38K |
| 5 |
Morgan Stanley
New York
|
+$4.85K |
Top Sellers
| 1 | -$875K | |
| 2 | -$103K | |
| 3 | -$29.7K | |
| 4 |
BlackRock
New York
|
-$25K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$22.2K |